Investigación

Leucemia y hemopatías pediátricas

Buscador de publicaciones

Publicaciones

  • Wlodarski MW, Hirabayashi S, Pastor V, Starý J, Hasle H, Masetti R, Dworzak M, Schmugge M, van den Heuvel-Eibrink M, Ussowicz M, De Moerloose B, Català-Temprano A, Smith OP, Sedlacek P, Lankester AC, Zecca M, Bordon V, Matthes-Martin S, Abrahamsson J, Kühl JS, Sykora KW, Albert MH, Przychodzien B, Maciejewski JP, Schwarz S, Göhring G, Schlegelberger B, Cseh A, Noellke P, Yoshimi A, Locatelli F, Baumann I, Strahm B, Niemeyer CM and EWOG-MDS.

    Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents

    Blood . 127(11): 1387-1397. Nº de citas: 279

    [doi:10.1182/blood-2015-09-669937]

  • Cseh AM, Niemeyer CM, Yoshimi A, Català-Temprano A, Frühwald MC, Hasle H, van den Heuvel-Eibrink MM, Lauten M, De Moerloose B, Smith OP, Bernig T, Gruhn B, Kulozik AE, Metzler M, Olcay L, Suttorp M, Furlan I, Strahm B and Flotho C.

    Therapy with low-dose azacitidine for MDS in children and young adults: a retrospective analysis of the EWOG-MDS study group

    BRITISH JOURNAL OF HAEMATOLOGY . 172(6): 930-936. Nº de citas: 27

    [doi:10.1111/bjh.13915]

  • Berrueco R, Alonso-Saladrigues A, Martorell-Sampol L, Català-Temprano A, Ruiz-Llobet A, Toll T, Torrebadell-Burriel M, Naudo-Lahoz M, Camós-Guijosa M and Rives-Solà S.

    Outcome and toxicities associated to chemotherapy in children with acute lymphoblastic leukemia and Gilbert syndrome. Usefulness of UGT1A1 mutational screening

    PEDIATRIC BLOOD & CANCER . 62(7): 1195-1201. Nº de citas: 8

    [doi:10.1002/pbc.25457]

  • Barneda-Zahonero B, Collazo O, Azagra A, Fernández-Duran I, Serra-Musach J, Islam AB, Vega-García N, Malatesta R, Camós-Guijosa M, Gómez A, Román-González L, Vidal A, López-Bigas N, Villanueva A, Esteller M and Parra M.

    The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma

    CELL DEATH & DISEASE . 6: 1635. Nº de citas: 40

    [doi:10.1038/cddis.2014.594]

  • Niemeyer CM, Loh ML, Cseh A, Cooper T, Dvorak CC, Chan R, Xicoy B, Germing U, Kojima S, Manabe A, Dworzak M, De Moerloose B, Starý J, Smith OP, Masetti R, Català-Temprano A, Bergstraesser E, Ussowicz M, Fabri O, Baruchel A, Cavé H, Zwaan M, Locatelli F, Hasle H, van den Heuvel-Eibrink MM, Flotho C and Yoshimi A.

    Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia

    HAEMATOLOGICA . 100(1): 17-22. Nº de citas: 33

    [doi:10.3324/haematol.2014.109892]

  • Guerrero-Murillo M, Rill-Hinarejos A, Trincado JL, Bataller A, Ortiz-Maldonado V, Benítez-Ribas D, Español-Rego M, González-Navarro EA, Martínez-Cibrián N, Marchese D, Martín-Martín L, Martín García-Sancho A, Rives-Solà S, Heyn H, Juan M, Urbano-Ispizúa Á, Delgado J, Orfao A, Mereu E, Bueno C and Menendez P.

    Integrative single-cell multi-omics of CD19-CAR(pos) and CAR(neg) T cells suggest drivers of immunotherapy response in B cell neoplasias.

    CELL REPORTS MEDICINE . : 101803-101803.

    [doi:10.1016/j.xcrm.2024.101803]

  • Theron A, Alonso-Saladrigues A, Dapena JL, López-Duarte M, Diaz de Heredia C, Verdú-Amorós J, Sarrate E, Esperanza-Cebollada E, Cuatrecasas E, Andreu S, Conde N, Sanchez-Sierra N, Isola I, Camós-Guijosa M, Torrebadell-Burriel M, Rives-Solà S and Català-Temprano A.

    Secondary haematological dysplasia after CAR-T-cell therapy for acute lymphoblastic leukaemia in children.

    BRITISH JOURNAL OF HAEMATOLOGY . : .

    [doi:10.1111/bjh.19862]